HPP1-mediated tumor suppression requires activation of STAT1 pathways

被引:32
|
作者
Elahi, Abu [1 ]
Zhang, Li [2 ]
Yeatman, Timothy J. [1 ]
Gery, Sigal [3 ]
Sebti, Said [1 ]
Shibata, David [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA 90048 USA
关键词
HPP1; STAT1; colon cancer; tumor suppressor;
D O I
10.1002/ijc.23202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HPP1 is a recently discovered gene that is epigenetically silenced in a number of tumor types, suggesting a potential role as a tumor suppressor. However, whether HPP1 has tumor suppressor activity is not clearly known. We have sought to investigate the effects of HPP1 on tumor growth and survival and to identify signaling pathways that mediate HPP1's mechanism of action. Forced expression of HPP1 into HCT116 colon cancer cell lines blocked the ability of HCT116 tumors to grown in vivo in nude mice. In cell culture, ectopic expression of HPP1 induces apoptosis and potently inhibits soft agar colony formation. HPP1 overexpression was also associated with a moderate reduction in in vitro proliferation characterized by an accumulation of cells in the G0/G1 phase of the cell cycle. Microarray analysis revealed that ectopic expression of HPP1 resulted in a dramatic upregulation of STAT1 as well as a large number of associated interferon-inducible genes. RNA interference-mediated abrogation of STAT1 reversed HPP1's antiproliferative effects. We conclude that HPP1 demonstrates tumor suppressive and pro-apoptotic activity, both in vitro and in vivo. Coupled with its inactivation in a number of tumor types, our data provides evidence to support the role of HPP1 as a tumor suppressor gene. Moreover, activation of the STAT1 pathway likely represents the principal mediator of HPP1's tumor suppressive properties. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 50 条
  • [41] Activation of STAT1 & STAT4 by type 1 interferons: differential modulation by dexamethasone
    Fahey, AJ
    Robins, RA
    Constantinescu, CS
    IMMUNOLOGY, 2005, 116 : 103 - 103
  • [42] STAT1-mediated translational control in tumor suppression and antitumor therapies
    Wang, Shuo
    Koromilas, Antonis E.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (03):
  • [43] Role of tyrosine 441 of interferon-γ receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation
    Qing, Y
    Costa-Pereira, AP
    Watling, D
    Stark, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) : 1849 - 1853
  • [44] SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation
    Rogers, RS
    Horvath, CM
    Matunis, MJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) : 30091 - 30097
  • [45] Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
    Zemek, Rachael M.
    De Jong, Emma
    Chin, Wee Loong
    Schuster, Iona S.
    Fear, Vanessa S.
    Casey, Thomas H.
    Forbes, Cath
    Dart, Sarah J.
    Leslie, Connull
    Zaitouny, Ayham
    Small, Michael
    Boon, Louis
    Forrest, Alistair R. R.
    Muiri, Daithi O.
    Degli-Esposti, Mariapia A.
    Millward, Michael J.
    Nowak, Anna K.
    Lassmann, Timo
    Bosco, Anthony
    Lake, Richard A.
    Lesterhuis, W. Joost
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (501)
  • [46] Alternative activation of STAT1 and STAT3 in response to interferon-γ
    Qing, YL
    Stark, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41679 - 41685
  • [47] Distinct activation of STAT1 & STAT3 by the EGF receptor.
    Cheng, HYY
    Lieberman, MW
    BLOOD, 2003, 102 (11) : 203B - 204B
  • [48] Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells
    Kirito, K
    Nagashima, T
    Ozawa, K
    Komatsu, N
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) : 51 - 54
  • [49] Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
    Keita Kirito
    Toshihiro Nagashima
    Keiya Ozawa
    Norio Komatsu
    International Journal of Hematology, 2002, 75 : 51 - 54
  • [50] Interferon-α-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cδ and JNK
    Zhao, KW
    Li, D
    Zhao, Q
    Huang, Y
    Silverman, RH
    Sims, PJ
    Chen, GQ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) : 42707 - 42714